During Inflexion’s ownership, the company expanded its international operations by launching a new office in the US to target North American pharma clients.
Inflexion managing partner Simon Turner said, “We backed an experienced management team led by Stella Donoghue and we were able to recruit a highly regarded, tenacious, Chairman, Steven Kent.
“We have enjoyed a great working relationship with Steven and the whole team. The company is now well positioned to capitalise on its next stage of growth with Bridgepoint Development Capital and we wish the team every success in the future.”
Copyright © 2014 AltAssets